WIDE MOAT STOCKS COMPARISON

Checking

 

Stock Comparison

Boston Scientific Corporation vs Coloplast A/S

Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.

Boston Scientific Corporation

BSX · New York Stock Exchange

Market cap (USD)$71B
Gross margin (TTM)71.2%
Operating margin (TTM)21.5%
Net margin (TTM)17.5%
SectorHealthcare
IndustryMedical devices
CountryUS
Data as of2026-08-23
66/100
Moat score

Partial score covering 86% of segment weight.

Full stock profile

Dive deeper into Boston Scientific Corporation's moat claims, evidence, and risks.

View BSX analysis

Coloplast A/S

COLOB · Nasdaq Copenhagen

Market cap (USD)$14.2B
Gross margin (TTM)67.2%
Operating margin (TTM)14.9%
Net margin (TTM)9.7%
SectorHealthcare
IndustryMedical instruments and supplies
CountryDK
Data as of2026-08-23
87/100
Moat score

Partial score covering 76% of segment weight.

Full stock profile

Dive deeper into Coloplast A/S's moat claims, evidence, and risks.

View COLOB analysis

Comparison highlights

  • Segment focus: Boston Scientific Corporation has 4 segments (66.9% in Cardiovascular); Coloplast A/S has 5 segments (35.5% in Ostomy Care).
  • Moat breadth: Boston Scientific Corporation has 3 moat types across 2 domains; Coloplast A/S has 3 across 1.

Primary market context

Boston Scientific Corporation

Cardiovascular

Market

Cardiovascular devices (interventional cardiology, vascular therapies, structural heart, electrophysiology, cardiac rhythm management, remote monitoring, and interventional oncology/embolization)

Geography

Global

Customer

Hospitals/cath labs/EP labs and specialty clinics (cardiologists, electrophysiologists, vascular specialists, interventional radiologists/oncologists)

Role

Medical device OEM / implantables + procedure devices + service-enabled monitoring

Revenue share

66.9%

Coloplast A/S

Ostomy Care

Market

Ostomy care products (bags, plates, supporting products)

Geography

Global

Customer

Healthcare providers and distributors; end-users are ostomy patients

Role

Medical device manufacturer (disposable consumables)

Revenue share

35.5%

Side-by-side metrics

Boston Scientific Corporation
Coloplast A/S
Ticker / Exchange
BSX - New York Stock Exchange
COLOB - Nasdaq Copenhagen
Market cap (USD)
$71B
$14.2B
Gross margin (TTM)
71.2%
67.2%
Operating margin (TTM)
21.5%
14.9%
Net margin (TTM)
17.5%
9.7%
Sector
Healthcare
Healthcare
Industry
Medical devices
Medical instruments and supplies
HQ country
US
DK
Primary segment
Cardiovascular
Ostomy Care
Market structure
Oligopoly
Oligopoly
Market share
n/a
35%-40% (reported)
HHI estimate
n/a
n/a
Pricing power
Moderate
Moderate
Moat score
66 / 100 (partial, 86% coverage)
87 / 100 (partial, 76% coverage)
Moat domains
Demand, Legal
Demand
Last update
2026-09-05
2026-09-05

Moat coverage

Shared moat types

Training Org Change Costs

Boston Scientific Corporation strengths

Installed Base ConsumablesRegulated Standards Pipe

Coloplast A/S strengths

Habit DefaultBrand Trust

Segment mix

Boston Scientific Corporation segments

Full profile >

Endoscopy

Oligopoly

14.4%

Urology

Competitive

12.5%

Neuromodulation

Oligopoly

6.2%

Cardiovascular

Oligopoly

66.9%

Coloplast A/S segments

Full profile >

Ostomy Care

Oligopoly

35.5%

Continence Care

Oligopoly

32.2%

Voice & Respiratory Care

Oligopoly

8.2%

Wound & Tissue Repair

Competitive

14.1%

Interventional Urology

Oligopoly

10%

Act on this comparison

Want the full wide moat stocks list?

Browse the full ranking of wide moat stocks, updated with moat scores and segment context.

View the moat stocks list

Curation & Accuracy

This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).

Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.